Tuas pharmaceutical facility put up for sale at $90m
The nine-hectare site has about 535,000 sq ft of untapped gross floor area for potential expansion.
A pharmaceutical manufacturing facility at 21 Tuas South Avenue 6 has been put up for sale by private treaty at an indicative price of $90m.
Cushman & Wakefield, the exclusive marketing agent, said the property occupies about 935,341 square feet (sq ft) of land and has an existing gross floor area of 397,387 sq ft.
With a plot ratio of 1.0, the site provides approximately 535,000 sq ft of untapped gross floor area, including a greenfield parcel that could support expansion or redevelopment.
The ready-built facility has about 32 years remaining on its tenure, with nominal annual land rent payable.
It is located within Tuas Biomedical Park, near pharmaceutical and biotechnology companies and the upcoming Tuas Mega Port.
Cushman & Wakefield said the location could support more efficient global distribution of temperature-sensitive pharmaceutical products.